SWI/SNF acts as both a repressor and an activator of gene transcription, and mutations to the complex have been shown in 20–25% of all human cancers [136], with the gene for ARID1A being the most frequently mutated gene in the SWI/SNF complex. The gene discussed is SMARCA1; the disease is cancer.